Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acrivastine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102311381A details a high-purity Heck coupling method for Acrivastine precursors, offering superior selectivity and simplified purification for pharmaceutical manufacturing.